Cargando…
SHP-1/STAT3 Interaction Is Related to Luteolin-Induced Myocardial Ischemia Protection
Prevention and management of myocardial ischemia/reperfusion (I/R) injury is a key step in coronary heart disease surgery. Luteolin is a falconoid compound that has an antioxidant effect, but its mechanism in I/R injury in vivo and in vitro is still under explored. This study attempted to reveal the...
Autores principales: | Liu, Donghai, Luo, Hong, Qiao, Chenhui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8403691/ https://www.ncbi.nlm.nih.gov/pubmed/34460026 http://dx.doi.org/10.1007/s10753-021-01530-y |
Ejemplares similares
-
Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
por: Song, Shiyu, et al.
Publicado: (2017) -
Correction: Luteolin selectively kills STAT3 highly activated gastric cancer cells through enhancing the binding of STAT3 to SHP-1
por: Song, Shiyu, et al.
Publicado: (2018) -
Luteolin Inhibits Ischemia/Reperfusion-Induced Myocardial Injury in Rats via Downregulation of microRNA-208b-3p
por: Bian, Chen, et al.
Publicado: (2015) -
Luteolin Treatment Protects against Renal Ischemia-Reperfusion Injury in Rats
por: Hong, Xin, et al.
Publicado: (2017) -
Dexmedetomidine Pretreatment Protects Against Myocardial Ischemia/Reperfusion Injury by Activating STAT3 Signaling
por: Chen, Zhao-Rong, et al.
Publicado: (2023)